CD28-mediated co-stimulation: a quantitative support for TCR signalling.
The DOI matches its Crossref record; 160 of the 160 references it cites were found in a registry or an index.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Under physiological conditions CD28-derived signals alone are not capable of inducing T cell activation, whereas simultaneous engagement of the TCR and CD28 (e.g. by its natural ligands CD80 and CD86 which are expressed on mature antigen presenting cells) leads to activation of resting T lymphocytes (reviewed in [3], [4]).”
From Signaling Signatures and Functional Properties of Anti-Human CD28 Superagonistic Antibodies (2008) · cites this paper as [3]
In the citing paper
“Under physiological conditions CD28-derived signals alone are not capable of inducing T cell activation, whereas simultaneous engagement of the TCR and CD28 (e.g. by its natural ligands CD80 and CD86 which are expressed on mature antigen presenting cells) leads to activation of resting T lymphocytes (reviewed in [3], [4]).”
From Signaling Signatures and Functional Properties of Anti-Human CD28 Superagonistic Antibodies (2008) · cites this paper as [3]
In the citing paper
“In mouse and human T cells the dimeric transmembrane glycoprotein CD28 represents the most important co-stimulatory molecule.”
From Signaling Signatures and Functional Properties of Anti-Human CD28 Superagonistic Antibodies (2008) · cites this paper as [3]
Citations
Cites
CDK inhibitors: positive and negative regulators of G1-phase progression
Sherr, C. J., & Roberts, J. M. (1999) · Genes & Development · doi:10.1101/gad.13.12.1501 · Cited by 6,115
CD28/B7 SYSTEM OF T CELL COSTIMULATION
Lenschow, D. J., Walunas, T. L., & Bluestone, J. A. (1996) · Annual Review of Immunology · doi:10.1146/annurev.immunol.14.1.233 · Cited by 2,717 · cited 6×
“This phosphorylation requires PtdIns(3,4,5)P 3 -activated AKT kinase and it is sensitive to inhibition by pharma cological inhibitors of PI3K(25,45).”
BackgroundInfluentialTOR, a Central Controller of Cell Growth
Schmelzle, T., & Hall, M. N. (2000) · Cell · doi:10.1016/s0092-8674(00)00117-3 · Cited by 1,924
Sharpe, A. H., & Freeman, G. J. (2002) · Nature Reviews Immunology · doi:10.1038/nri727 · Cited by 1,712 · cited 7×
“This phosphorylation requires PtdIns(3,4,5)P 3 -activated AKT kinase and it is sensitive to inhibition by pharma cological inhibitors of PI3K(25,45).”
BackgroundInfluentialThe lineage decisions of helper T cells
Murphy, K. M., & Reiner, S. L. (2002) · Nature Reviews Immunology · doi:10.1038/nri954 · Cited by 1,674
Schwartz, R. H. (2003) · Annual Review of Immunology · doi:10.1146/annurev.immunol.21.120601.141110 · Cited by 1,487
The CD28 Signaling Pathway Regulates Glucose Metabolism
Frauwirth, K. A., Riley, J. L., Harris, M. H., Parry, R. V., Rathmell, J. C., Plas, D. R., Elstrom, R. L., June, C. H., & Thompson, C. B. (2002) · Immunity · doi:10.1016/s1074-7613(02)00323-0 · Cited by 1,475 · cited 1×
“CD28-induced activation of AKT upregulates glucose metabolis”
Differential T Cell Costimulatory Requirements in CD28-Deficient Mice
Shahinian, A., Pfeffer, K., Lee, K. P., Kündig, T. M., Kishihara, K., Wakeham, A., Kawai, K., Ohashi, P. S., Thompson, C. B., & Mak, T. W. (1993) · Science · doi:10.1126/science.7688139 · Cited by 1,257 · cited 7×
“This phosphorylation requires PtdIns(3,4,5)P 3 -activated AKT kinase and it is sensitive to inhibition by pharma cological inhibitors of PI3K(25,45).”
BackgroundInfluentialCD28 costimulation can promote T cell survival by enhancing the expression of Bcl-xL
Boise, L. H., Minn, A. J., Noel, P. J., June, C. H., Accavitti, M. A., Lindsten, T., & Thompson, C. B. (1995) · Immunity · doi:10.1016/1074-7613(95)90161-2 · Cited by 1,210
T Cell Activation Determined by T Cell Receptor Number and Tunable Thresholds
Viola, A., & Lanzavecchia, A. (1996) · Science · doi:10.1126/science.273.5271.104 · Cited by 1,023 · cited 1×
“This is also indicated by studies showing that CD28 ligation lowers the number of triggered TCRs that are required for a given respons”
Background
Cited by
Items 301–400 of 797
Imaging Membrane Order and Dynamic Interactions in Living Cells with a DNA Zipper Probe
Bagheri, Y., Ali, A. A., Keshri, P., Chambers, J. J., Gershenson, A., & You, M. (2021) · Angewandte Chemie International Edition · doi:10.1002/anie.202112033 · Cited by 38
Engineering γδ T Cells: Recognizing and Activating on Their Own Way
Dong, R., Zhang, Y., Xiao, H., & Zeng, X. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.889051 · Cited by 42
Wang, Z., Xie, S., Wu, L., Chen, F., Qiu, L., & Tan, W. (2022) · Nano Letters · doi:10.1021/acs.nanolett.2c02522 · Cited by 37
Nguyen, H., & Weng, N.-P. (2009) · Journal of Leukocyte Biology · doi:10.1189/jlb.0209086 · Cited by 37
SOCS1: Regulator of T Cells in Autoimmunity and Cancer
Ilangumaran, S., Bobbala, D., & Ramanathan, S. (2017) · Current topics in microbiology and immunology · doi:10.1007/82_2017_63 · Cited by 41
Hoyer, K. K., Herling, M., Bagrintseva, K., Dawson, D. W., French, S. W., Renard, M., Weinger, J. G., Jones, D., & Teitell, M. A. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.2.864 · Cited by 37
Immunoporosis: The hidden link between aging immune cells and bone fragility
Cheng, X., Chen, Y., Zhou, X., Gu, Q., Zhao, H., Wan, C., Chen, M., Yang, H., & Shi, Q. (2025) · Journal of Orthopaedic Translation · doi:10.1016/j.jot.2025.06.015 · Cited by 44
“Noticeably, CD28 is considered critical, serving as a second co-stimulatory signal to T cell activation [85].”
Blockade of murine T cell activation by antagonists of P2Y6 and P2X7 receptors
Tsukimoto, M., Tokunaga, A., Harada, H., & Kojima, S. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.05.011 · Cited by 37
“Activation of these signaling pathways leads to production of interleukin (IL)-2, which plays a critical role in the activation and proliferation of T cells [2].”
BackgroundInfluentialERK Activation in CAR T Cells Is Amplified by CD28-Mediated Increase in CD3ζ Phosphorylation
Rohrs, J. A., Siegler, E. L., Wang, P., & Finley, S. D. (2020) · iScience · doi:10.1016/j.isci.2020.101023 · Cited by 37
Sanchez-Lockhart, M., & Miller, J. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.8.4778 · Cited by 35
“Despite the well-recognized functional importance of CD28, the biochemical signaling pathways induced downstream of CD28 are still not completely understood (1, 4).”
BackgroundXiao, K., Lai, Y., Yuan, W., Li, S., Liu, X., Xiao, Z., & Xiao, H. (2023) · Interdisciplinary medicine · doi:10.1002/inmd.20230036 · Cited by 41
Zhu, E., Yu, J., Li, Y.-R., Ma, F., Wang, Y.-C., Liu, Y., Li, M., Kim, Y. J., Zhu, Y., Hahn, Z., et al. (2024) · Nature Nanotechnology · doi:10.1038/s41565-024-01781-4 · Cited by 39
“…molecules per µm 2 ) 25–28 , the required human peptide major histocompatibility complex (pMHC) surface density for TCR activation (90–140 molecules per µm 2 minimum 29 , ~500 molecules per µm 2 saturated 30 ), and the human physiological CD28 density (100–610 molecules per µm 2 ) 25,26,31 .”
BackgroundZhao, C., Fu, M., Wang, C., Jiao, Z., & Qiu, L. (2016) · Fish & Shellfish Immunology · doi:10.1016/j.fsi.2016.02.032 · Cited by 37
“The interplay between CD28 and its ligands is required for T lymphocyte activation [61].”
BackgroundUnusual CD4+CD28−T Cells and Their Pathogenic Role in Chronic Inflammatory Disorders
Lee, G. H., & Lee, W. (2016) · Immune Network · doi:10.4110/in.2016.16.6.322 · Cited by 38
Biswas, A., Banerjee, P., & Biswas, T. (2009) · Molecular Immunology · doi:10.1016/j.molimm.2009.06.006 · Cited by 36
Novel mechanism of signaling by CD28
Bjørgo, E., & Taskén, K. (2010) · Immunology Letters · doi:10.1016/j.imlet.2010.01.007 · Cited by 35
F-Actin-Driven CD28-CD80 Localization in the Immune Synapse
Siokis, A., Robert, P. A., Demetriou, P., Dustin, M. L., & Meyer‐Hermann, M. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.06.114 · Cited by 35
Blocking Effect of an Immuno-Suppressive Agent, Cynarin, on CD28 of T-Cell Receptor
Dong, G., Chuang, P.-H., Chang, K.-C., Jan, P.-S., Hwang, P.-I., Wu, H.-B., Yi, M., Zhou, H., & Chen, H. M. (2008) · Pharmaceutical Research · doi:10.1007/s11095-008-9754-5 · Cited by 38
Two pathways of costimulation through CD28
Miller, J., Baker, C. M., Cook, K. D., Graf, B. A., Sánchez-Lockhart, M., Sharp, K., Wang, X., Yang, B. C., & Yoshida, T. (2009) · Immunologic Research · doi:10.1007/s12026-009-8097-6 · Cited by 40
Franzese, O., Palermo, B., Donna, C. D., Sperduti, I., Ferraresi, V., Stabile, H., Gismondi, A., Santoni, A., & Nisticò, P. (2016) · OncoImmunology · doi:10.1080/2162402x.2015.1114203 · Cited by 39
Trendel, N., Krüger, P., Gaglione, S. A., Nguyen, J., Pettmann, J., Sontag, E. D., & Dushek, O. (2021) · Science Signaling · doi:10.1126/scisignal.aay9363 · Cited by 37
Huang, X., Guo, J., Li, T., Jia, L., Tang, X., Zhu, J., Tang, Q., & Feng, Z. (2022) · Journal of Biomedical Research · doi:10.7555/jbr.35.20200207 · Cited by 34
“In our previous research, the human anti-c-Met Fab antibody was screened, identified[15], and conjugated with doxorubicin (Dox) to prepare c-Met Fab-DOX, then its binding activity to HCC cells and its cytotoxic effects on HCC cells were detected[18].”
MethodClinical consequences of circulating CD28-negative T cells for solid organ transplantation
Betjes, M. G. H. (2015) · Transplant International · doi:10.1111/tri.12658 · Cited by 35
“Adequate costimulation is essential for the proliferation of na€ıve T cells, and a pivotal system in this respect is the CD28–CD80/86 axis [9,10].”
BackgroundSchneider, O. D., Weiss, A. A., & Miller, W. E. (2007) · Infection and Immunity · doi:10.1128/iai.00414-07 · Cited by 33
“When CD28 and the TCR are simultaneously engaged by their cognate ligands, T-cell activation is strongly enhanced ( 2 , 18, 22, 26, 41, 48, 50).”
BackgroundWang, Z., Zhang, Y., Wu, L., Chen, J., Xie, S., He, J., Zhang, Q., Chen, H., Chen, F., Liu, Y., et al. (2023) · Angewandte Chemie International Edition · doi:10.1002/anie.202307656 · Cited by 33
Chimeric Antigen Receptor T Cell Therapy for Hepatocellular Carcinoma: Where Do We Stand?
Aggeletopoulou, I., Kalafateli, M., & Triantos, C. K. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25052631 · Cited by 36
“This modification results in improved T cell activation, proliferation, and persistence leading to enhanced antitumor activity [27,28].”
BackgroundCo-stimulate or Co-inhibit Regulatory T Cells, Which Side to Go?
Liu, W., Almo, S. C., & Zang, X. (2016) · Immunological Investigations · doi:10.1080/08820139.2016.1186690 · Cited by 34
“CD28, the prototypical co-stimulatory receptor, is constitutively expressed on almost all human CD4+ T cells and on about half of human CD8+ T cells, whereas it is expressed on almost all matured CD4+ and CD8+ T cells in mouse (Acuto & Michel, 2003).”
BackgroundImmune Checkpoint Blockade in Breast Cancer Therapy
Bu, X., Yao, Y., & Li, X. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-981-10-6020-5_18 · Cited by 36
Engineering Cytoplasmic Signaling of CD28ζ CARs for Improved Therapeutic Functions
Meng, X., Jing, R., Qian, L., Zhou, C., & Sun, J. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01046 · Cited by 31
“Third, in human T cells, CD28 and TCR are normally expressed at ∼6 × 104 and ∼2 × 104 molecules per cell (41).”
BackgroundType I interferon potentiates T ‐cell receptor mediated induction of IL ‐10‐producing CD 4+ T cells
Corre, B., Perrier, J., Khouri, M. E., Cerboni, S., Pellegrini, S., & Michel, F. (2013) · European Journal of Immunology · doi:10.1002/eji.201242977 · Cited by 35
Self-citationPosttranscriptional regulation of T helper cell fate decisions
Hoefig, K. P., & Heissmeyer, V. (2018) · The Journal of Cell Biology · doi:10.1083/jcb.201708075 · Cited by 34
“It also leads to cytoskeletal rearrangements, enhances signal transduction from the TCR, and activates mTOR to increase the metabolic activity of the cell (Acuto and Michel, 2003; Okkenhaug and Vanhaesebroeck, 2003; Gamper and Powell, 2012).”
BackgroundBiophysical basis underlying dynamic Lck activation visualized by ZapLck FRET biosensor
Wan, R., Wu, J., Ouyang, M., Lei, L., Wei, J., Peng, Q., Harrison, R. E. S., Wu, Y., Cheng, B., Li, K., et al. (2019) · Science Advances · doi:10.1126/sciadv.aau2001 · Cited by 32
Muscolini, M., Camperio, C., Porciello, N., Caristi, S., Capuano, C., Viola, A., Galandrini, R., & Tuosto, L. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1401643 · Cited by 30
“2/CD86, provides key TCR-dependent (1, 2) and TCR-independent signals (2–6) necessary for the optimal activation of T lymphocytes.”
BackgroundNeutrophils-typical atypical antigen presenting cells?
Polak, D., & Bohle, B. (2022) · Immunology Letters · doi:10.1016/j.imlet.2022.04.007 · Cited by 33
Duwa, R., Pokhrel, R. H., Banstola, A., Pandit, M., Shrestha, P. S., Jeong, J., Chang, J., & Yook, S. (2022) · Biomaterials · doi:10.1016/j.biomaterials.2022.121911 · Cited by 30
Chimeric antigen receptor T-cell therapy for T-ALL and AML
Wei, W., Yang, D. F., Chen, X., Liang, D., Zou, L., & Zhao, X. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.967754 · Cited by 32
“Although these represent a good safety profile in tumor therapy, their efficacy was not significantly improved compared with the second generation CAR (43).”
BackgroundProtein arginine methylation in lymphocyte signaling
Blanchet, F. P., Schurter, B. T., & Acuto, O. (2006) · Current Opinion in Immunology · doi:10.1016/j.coi.2006.03.001 · Cited by 31
Self-citationCutting Edge: A Role for Inside-Out Signaling in TCR Regulation of CD28 Ligand Binding
Sánchez-Lockhart, M., Kim, M., & Miller, J. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1102497 · Cited by 38
“Most functions of CD28 are associated with modulation of TCR function, primarily by enhancing the magnitude of TCR signaling (10).”
BackgroundMiyazaki, Y., Iwabuchi, K., Kikuchi, S., Fukazawa, T., Niino, M., Hirotani, M., Sasaki, H., & Onoé, K. (2008) · Multiple Sclerosis Journal · doi:10.1177/1352458508092809 · Cited by 31
“CD28 is a co-stimulatory molecule expressed on the surface of T cells, which receives signals from its ligands (CD80/CD86) expressed on antigen presenting cells [9].”
BackgroundSulzgruber, P., Thaler, B., Koller, L., Baumgartner, J., Pilz, A., Steininger, M., Schnaubelt, S., Fleck, T., Laufer, G., Steinlechner, B., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-28046-0 · Cited by 31
Modulating co-stimulation: a rational strategy in the treatment of rheumatoid arthritis?
Malmström, V., Trollmo, C., & Klareskog, L. (2005) · Arthritis Research & Therapy · doi:10.1186/ar1505 · Cited by 36
CAR-T-Cell Therapy for Systemic Lupus Erythematosus: A Comprehensive Overview
Abdalhadi, H., Chatham, W. W., & Alduraibi, F. K. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms251910511 · Cited by 31
“Second-generation CAR-T cells incorporate costimulatory domains, mainly CD28 or 4-1BB, in addition to CD3 ζ chains, which increase their T-cell activity, survival, and cytotoxicity [52–56].”
BackgroundKavazović, I., Polić, B., & Wensveen, F. M. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02831 · Cited by 31
“Conversely, high antigen doses and prolonged antigen stimulation can compensate for a lack of CD28 co-stimulation in vivo (35, 36).”
BackgroundImmunotherapies against HER2-Positive Breast Cancer
Duro‐Sánchez, S., Alonso, M. R., & Arribas, J. (2023) · Cancers · doi:10.3390/cancers15041069 · Cited by 39
Gene expression and generation of CD28−CD8 T cells mediated by interleukin 15
Godlove, J. M., CHIU, W., & Weng, N. (2007) · Experimental Gerontology · doi:10.1016/j.exger.2006.11.015 · Cited by 29
“Because CD28 provides a pivotal role during T cell activation, such as inducing cytokine production (IL-2) and promoting cell proliferation (Acuto and Michel, 2003), lack of this co-stimulatory signal during activation results in a partial activation or even an anergy state of T cells.”
BackgroundCarreño, L. J., Bueno, S. M., Bull, P., Nathenson, S. G., & Kalergis, A. M. (2007) · Immunology · doi:10.1111/j.1365-2567.2007.02561.x · Cited by 29
Sacristán, C., Schattgen, S., Berg, L. J., Bunnell, S. C., Roy, A. L., & Rosenstein, Y. (2009) · European Journal of Immunology · doi:10.1002/eji.200839031 · Cited by 28
Molecular characterization of Cynoglossus semilaevis CD28
Hu, Y., Sun, B.-G., Deng, T., & Sun, L. (2012) · Fish & Shellfish Immunology · doi:10.1016/j.fsi.2012.02.021 · Cited by 28
Muscolini, M., Camperio, C., Capuano, C., Caristi, S., Piccolella, E., Galandrini, R., & Tuosto, L. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1203157 · Cited by 31
“TCR activation threshold, thus leading to the enhancement of early signaling events necessary for efficient cytokine production, cell cycle progression, survival, and regulation of T cell effector responses (1, 2).”
BackgroundEffects of Aloe barbadensis Mill. extract (AVH200®) on human blood T cell activity in vitro
Ahluwalia, B., Magnusson, M. K., Isaksson, S., Larsson, F., & Öhman, L. (2016) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2016.01.003 · Cited by 28
Regulation of SATB1 during thymocyte development by TCR signaling
Gottimukkala, K. P., Jangid, R. K., Patta, I., Sultana, D. A., Sharma, A., Misra-Sen, J., & Galande, S. (2016) · Molecular Immunology · doi:10.1016/j.molimm.2016.07.005 · Cited by 30
“Since an effective TCR signal transduction pathway involves signaling via the TCR and coreceptors such as CD28 (Acuto and Michel, 2003), we activated CD4+ T cells in timedependent manner using only anti-CD3 or anti-CD28 or both.”
MethodMak, T. W., & Saunders, M. E. (2006) · Elsevier eBooks · doi:10.1016/b978-012088451-3.50016-8 · Cited by 28
TCR-Dependent Cell Response Is Modulated by the Timing of CD43 Engagement
Fierro, N. A., Pedraza‐Alva, G., & Rosenstein, Y. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.12.7346 · Cited by 29
“CD28 is considered the hallmark of coreceptor molecules (44), and interestingly, CD43 has been shown to compensate for CD28 functions in the CD28 / mouse (45).”
BackgroundHaas, C., Lulei, M., Fournier, P., Arnold, A., & Schirrmacher, V. (2004) · Vaccine · doi:10.1016/j.vaccine.2004.10.031 · Cited by 28
CD28null T cells in aging and diseases: From biology to assessment and intervention
Guan, Y., Cao, M., Wu, X., Yan, J., Hao, Y., & Zhang, C. (2024) · International Immunopharmacology · doi:10.1016/j.intimp.2024.111807 · Cited by 28
The Late Endosomal Transporter CD222 Directs the Spatial Distribution and Activity of Lck
Pfisterer, K., Forster, F., Paster, W., Supper, V., Ohradanova‐Repic, A., Eckerstorfer, P., Zwirzitz, A., Donner, C., Boulègue, C., Schiller, H. B., et al. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1303349 · Cited by 29
“Interestingly, ligation of the common costimulatory molecule CD28, which also quantitatively enhances T cell responses to TCR stimuli (26), did not rescue, but even resulted in a more pronounced phenotype induced by silencing of CD222.”
BackgroundSelf-citationCD28 and Cd27 Costimulation of Cd8+ T Cells: A Story of Survival
Dolfi, D. V., & Katsikis, P. D. (2007) · Springer eBooks · doi:10.1007/978-0-387-34814-8_11 · Cited by 32
Liao, P., Wang, H., Tang, Y., Tang, Y.-J., & Liang, X. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02457 · Cited by 29
T-lymphocyte signalling in systemic lupus erythematosus: a lipid raft perspective
Jury, E. C., & Kabouridis, P. S. (2004) · Lupus · doi:10.1191/0961203304lu1045rr · Cited by 28
Huang, S.-W., Xu, T., Zhang, C.-T., & Zhou, H.-L. (2020) · The journal of nutrition health & aging · doi:10.1007/s12603-020-1329-0 · Cited by 28
Kunkl, M., Amormino, C., Caristi, S., Tedeschi, V., Fiorillo, M. T., Levy, R., Popugailo, A., Kaempfer, R. O. R., & Tuosto, L. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.723689 · Cited by 26
“The TCR and CD28 cooperate to provide signals required for efficient T-cell activation (17, 18, 60).”
BackgroundMethodIL-33 acts as a costimulatory signal to generate alloreactive Th1 cells in graft-versus-host disease
Dwyer, G. K., Mathews, L. R., Villegas, J. A., Lucas, A., de Peredo, A. G., Blazar, B. R., Girard, J., Poholek, A. C., Luther, S. A., Shlomchik, W. D., et al. (2022) · Journal of Clinical Investigation · doi:10.1172/jci150927 · Cited by 27
“While Th1 differentiation is typically thought to be dominated by innate cell-derived cytokine IL-12, the strength of TCR and costimulation signaling are highly influential in dic-tating CD4 + T cells’ differentiation fates (42–44).”
CD28−CD8+ T cells do not contain unique clonotypes and are therefore dispensable
Weinberger, B., Welzl, K., Herndler‐Brandstetter, D., Parson, W., & Grubeck‐Loebenstein, B. (2009) · Immunology Letters · doi:10.1016/j.imlet.2009.08.008 · Cited by 26
Large‐scale expansion of rat CD4+ CD25+ Treg cells in the absence of T‐cell receptor stimulation
Beyersdorf, N., Balbach, K., Hünig, T., & Kerkau, T. (2006) · Immunology · doi:10.1111/j.1365-2567.2006.02455.x · Cited by 32
Svane, I. M., Pedersen, A. E., Nikolajsen, K., & Zocca, M.-B. (2008) · Vaccine · doi:10.1016/j.vaccine.2008.06.085 · Cited by 27
Scottà, C., Soligo, M., Camperio, C., & Piccolella, E. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.2.1025 · Cited by 25
“However, the TCR and CD28 share many redundant downstream signaling pathways and often CD28 acts as an amplifier (1).”
BackgroundPoirier, N., Blancho, G., & Vanhove, B. (2010) · Immunotherapy · doi:10.2217/imt.10.57 · Cited by 25
Blaize, G., Daniels‐Treffandier, H., Aloulou, M., Rouquié, N., Yang, C., Marcellin, M., Gador, M., Benamar, M., Ducatez, M., Song, K., et al. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1917182117 · Cited by 27
“A molecular model to explain this effect was that strong, but not weak, TCR signals repress the expression of the PtdIns(3,4,5)P3 phosphatase and tensin homolog (PTEN), which is an inhibitor of the AKT signaling pathway (56).”
BackgroundRaimondi, G., Zanoni, I., Citterio, S., Ricciardi‐Castagnoli, P., & Granucci, F. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.7.4012 · Cited by 25
“Because costimulation could represent simply a synergism with signal one (32, 33), in our system the strength of signal one could be high enough to allow T cell activation and differentiation.”
BackgroundA Signal Integration Model of Thymic Selection and Natural Regulatory T Cell Commitment
Khailaie, S., Robert, P. A., Toker, A., Hühn, J., & Meyer‐Hermann, M. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1400889 · Cited by 29
“Regarding the role of costimulation, as generally accepted in T cell activation, higher costimulation provides higher signaling strength and increases the sensitivity of T cells to Ag stimulation (111).”
BackgroundIshikawa, T., Kokura, S., Enoki, T., Sakamoto, N., Okayama, T., Ideno, M., Mineno, J., Uno, K., Yoshida, N., Kamada, K., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0083786 · Cited by 25
“It has been suggested that CD28-expressing T cells secrete IL-2 and induce antiapoptotic molecules [23].”
BackgroundWafa, E. I., Geary, S. M., Ross, K. A., Goodman, J. T., Narasimhan, B., & Salem, A. K. (2018) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.118.252809 · Cited by 24
“The expression of these maturation markers contributes to their potency in subsequently activating CD8(1) T cells (Acuto and Michel, 2003; Liu et al., 2018).”
BackgroundZhou, L., Yang, J., Zhang, K., Wang, T., Jiang, S., & Zhang, X. (2024) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.3c01361 · Cited by 24
In the absence of its cytosolic domain, the CD28 molecule still contributes to T cell activation
Morin, S. O., Giroux, V., Favre, C., Bechah, Y., Auphan‐Anezin, N., Roncagalli, R., Mège, J., Olive, D., Malissen, M., & Nunès, J. A. (2015) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-015-1873-7 · Cited by 24
“coalescence [27].”
Antibody-Functionalized Nanowires: A Tuner for the Activation of T Cells
Bhingardive, V., Kossover, A., Iraqi, M., Khand, B., Saux, G. L., Porgador, A., & Schvartzman, M. (2021) · Nano Letters · doi:10.1021/acs.nanolett.1c00245 · Cited by 24
“57 − 59 Also, CD28 triggering is used to induce T cell e ff ector function for cancer immunotherapy.”
MethodSerra, A., Nuti, S., Tavarini, S., Sammicheli, C., Rosa, D., Saletti, G., Soldaini, E., Abrignani, S., & Wack, A. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.1.174 · Cited by 24
PmVAE: learning interpretable single-cell representations with pathway modules
Gut, G., Stark, S. G., Rätsch, G., & Davidson, N. R. (2021) · doi:10.1101/2021.01.28.428664 · Cited by 24
“CD28 activation, together with TCR activation, results in co-stimulatory pathway activations [1].”
BackgroundTNFR2 Costimulation Differentially Impacts Regulatory and Conventional CD4+ T-Cell Metabolism
Mensink, M., Zaal, E. A., Minh, T. T. N., Schrama, E., Berkers, C. R., Borst, J. G., & de Kivit, S. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.881166 · Cited by 23
“The transcriptomes of CD3- or CD3/CD28-stimulated tTregs and Tconvs clustered more closely 148 together, especially in Tconvs, likely due to the convergence of CD3- and CD28 signaling pathways 149 (78).”
Background1,25(OH)2D3 Promotes the Efficacy of CD28 Costimulation Blockade by Abatacept
Gardner, D. H., Jeffery, L. E., Soskic, B., Briggs, Z., Hou, T. Z., Raza, K., & Sansom, D. M. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1500306 · Cited by 25
“The concept that TCR and CD28 cooperate toward a combined activation threshold in which CD28 provides quantitative support to the TCR signal has been previously discussed (28).”
BackgroundTumor immunotherapy: drug-induced neoantigens (xenogenization) and immune checkpoint inhibitors
Franzese, O., Torino, F., Fuggetta, M. P., Aquino, A., Roselli, M., Bonmassar, E., Giuliani, A., & D’Atri, S. (2017) · Oncotarget · doi:10.18632/oncotarget.16335 · Cited by 23
“Co-stimulatory molecules play a critical role during T-cell activation by inducing cytokine production and promoting T-cell proliferation [68] and are essential for lowering the threshold of TCR activation, supporting the responses against low-affinity Ags [69].”
BackgroundGanguly, D., Paul, K., Bagchi, J., Rakshit, S., Mandal, L., Bandyopadhyay, G. K., & Bandyopadhyay, S. K. (2007) · Immunology · doi:10.1111/j.1365-2567.2007.02596.x · Cited by 26
The Role of CD97 in Regulating Adaptive T-Cell Responses
Spendlove, I., & Sutavani, R. V. (2010) · Advances in experimental medicine and biology · doi:10.1007/978-1-4419-7913-1_12 · Cited by 29
Kosmaczewska, A., Ciszak, L., Stosio, M., Szteblich, A., Madej, M., Frydecka, I., Wiland, P., & Szmyrka−Kaczmarek, M. (2020) · Lupus · doi:10.1177/0961203320917749 · Cited by 24
“This signal is transferred upon the binding of CD80 or CD86 ligands on the surface of antigen-presenting cells with CD28 on the surface of CD4þ T cells.(2) Loss of the CD28 molecule can be due to the proinflammatory milieu characterized by an excess of TNF-a and repeated antigen stimulation.”
BackgroundThe Impact of T-cell Aging on Alloimmunity and Inflammaging
Iske, J., Dedeilia, A., Xiao, Y., Martin, F., Emmert, M. Y., Sage, P. T., Abdi, R., Zhou, H., & Tullius, S. G. (2023) · Transplantation · doi:10.1097/tp.0000000000004715 · Cited by 23
“24 However, by age 80, 10% to 15% of CD4 + and 50% to 60% of CD8 + T cells lack the expression of CD28.”
BackgroundNeisseria gonorrhoeaeInduces a Tolerogenic Phenotype in Macrophages to Modulate Host Immunity
Escobar, A. F., Candía, E., Reyes-Cerpa, S., Villegas-Valdes, B., Neira-Peña, T., López, M. N., Maisey, K. R., Tempio, F., Ríos, M., Acuña‐Castillo, C., et al. (2013) · Mediators of Inflammation · doi:10.1155/2013/127017 · Cited by 22
“This suggests that, although Neisseria gonorrhoeae is actually phagocytosed by macrophages, the bacteria can weaken antigen-presenting functions because CD86/CD28 costimulatory pathway control of immune responses, such as antibody responses and induction of cytotoxic T-cell responses, is impaired in the absence of CD2…”
BackgroundAltered T cell costimulation during chronic hepatitis B infection
Barboza, L., Salmen, S., Peterson, D. L., Montes, H., Colmenares, M. C., Hernández, M. H., Berrueta-Carrillo, L., & Berrueta, L. (2009) · Cellular Immunology · doi:10.1016/j.cellimm.2009.02.008 · Cited by 22
Dagur, P. K., Sharma, B., Kumar, G., Khan, N. A., Katoch, V. M., Sengupta, U., & Joshi, B. (2009) · Molecular Immunology · doi:10.1016/j.molimm.2009.11.009 · Cited by 28
Riou, C., Dumont, A. R., Yassine‐Diab, B., Haddad, E. K., & Sékaly, R. (2006) · International Immunology · doi:10.1093/intimm/dxl019 · Cited by 24
Proteomic and protein interaction network analysis of human T lymphocytes during cell‐cycle entry
Orr, S. J., Boutz, D. R., Wang, R., Chronis, C., Lea, N. C., Thayaparan, T., Hamilton, E., Milewicz, H., Blanc, E., Mufti, G. J., et al. (2012) · Molecular Systems Biology · doi:10.1038/msb.2012.5 · Cited by 22
Vatzia, E., Pierron, A., Saalmüller, A., Mayer, E., & Gerner, W. (2019) · Toxins · doi:10.3390/toxins11110644 · Cited by 22
“Next to CD27, CD28 is a cell surface marker receptor that belongs to the immunoglobulin superfamily and is essential for T-cell activation, proliferation, and survival [20,21].”
BackgroundAgents of cancer immunosurveillance: HSPs and dsDNA
Nayak, D. A., & Binder, R. J. (2022) · Trends in Immunology · doi:10.1016/j.it.2022.03.004 · Cited by 23
Mechanisms of Allergic Contact Dermatitis
Rustemeyer, T., van Hoogstraten, I. M. W., Blomberg, B. M. E. V., & Scheper, R. J. (2019) · Springer eBooks · doi:10.1007/978-3-319-68617-2_14 · Cited by 23
Sánchez-Valdepeñas, C., Punzón, C., San-Antonio, B., Martín, Á. G., & Fresno, M. (2006) · Cellular Signalling · doi:10.1016/j.cellsig.2006.08.002 · Cited by 26
B7-H4 expression in bladder urothelial carcinoma and immune escape mechanisms
LIU, W.-H., CHEN, Y.-Y., ZHU, S.-X., Li, Y., Xu, Y., WU, X.-J., GUO, Y.-H., & Wang, J. C. (2014) · Oncology Letters · doi:10.3892/ol.2014.2522 · Cited by 22
“T lymphocytes are involved in the host adaptive immune response only when differentiated into functional T cells (27,28).”
Kounis, N. G., Koniari, I. C., TZANIS, G. L., Soufras, G., Velissaris, D., & Hahalis, G. N. (2020) · Annals of Cardiac Anaesthesia · doi:10.4103/aca.aca_100_19 · Cited by 21
“However, for T‐cell‐proliferation, regulation, activation, and cell‐survival a co‐stimulatory CD28‐receptor on CD4 T cells is needed.[9] On the basis of longstanding inflammatory conditions, CD4+ CD28+ T lymphocytes lose their expression of the CD28 antigen, and therefore, their sensitivity for both suppression and ap…”
BackgroundJiao, A., Sun, C., Wang, X., Lei, L., Liu, H., Li, W., Yang, X., Zheng, H., Ding, R., Zhu, K., et al. (2022) · Science Advances · doi:10.1126/sciadv.abk2691 · Cited by 21
The Immunological Synapse and Rho GTPases
Deckert, M., Moon, C., & Bras, S. L. (2005) · Current topics in microbiology and immunology · doi:10.1007/3-540-27511-8_5 · Cited by 24
Toxicological and pharmacological assessment of AGEN1884, a novel human IgG1 anti-CTLA-4 antibody
Gombos, R. B., Gonzalez, A., Manrique, M. L., Chand, D. S., Savitsky, D. A., Morin, B. M., Breous-Nystrom, E., Dupont, C. D., Ward, R., Mundt, C., et al. (2018) · PLoS ONE · doi:10.1371/journal.pone.0191926 · Cited by 21
Hyperresponse to T-Cell Receptor Signaling and Apoptosis of Id1 Transgenic Thymocytes
Qi, Z., & Sun, X.-H. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.17.7313-7323.2004 · Cited by 21
“One well-characterized costimulatory signal comes from the interaction between CD28 on CD4 T cells and CD80/CD86 on APC.”
BackgroundDesign and Evaluation of Synthetic Delivery Formulations for Peptide-Based Cancer Vaccines
Song, K., & Pun, S. H. (2024) · BME Frontiers · doi:10.34133/bmef.0038 · Cited by 20
“2 (CD86) on DCs interact with CD28 on T cells [34].”
Background
Metadata
- Authors
- Acuto, O., & Michel, F.
- Affiliations
- Institut Pasteur (FR)
- Corresponding author
- Acuto, Oreste
- ORCID
- Michel, Frédérique
- Venue
- Nature Reviews Immunology
- Published
- 2003-12
- Volume
- 3
- Issue
- 12
- Pages
- 939-951
- ISSN
- 1474-1733 (ISSN-L)
- 1474-1741
- OpenAlex
- W2055248228
- Cited by
- 775
- References
- 157
- Citations by year
- 2026: 26 · 2025: 32 · 2024: 31 · 2023: 23 · 2022: 42 · 2021: 33 · 2020: 32 · 2019: 25 · 2018: 38 · 2017: 43 · 2016: 42 · 2015: 35 · 2014: 29 · 2013: 37 · 2012: 33
- FWCI
- 2.57
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature reviews. Immunology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Association pour la Recherche sur le Cancer
- Centre National de la Recherche Scientifique
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
- Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
- Keywords
- CD28, costimulation, T cell receptor signaling, T cell activation, naive T cells, clonal expansion, costimulatory receptors, signal amplification
- MeSH terms
- Animals, Carrier Proteins, Cell Cycle, Humans, Lymphocyte Activation, Membrane Proteins, Phosphoproteins, T-Lymphocytes, Signal Transduction, CD28 Antigens, Phosphatidylinositol 3-Kinases, Adaptor Proteins, Signal Transducing, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.